FDA Inspection 1008325 — Octapharma Plasma, Inc. - Norfolk
The FDA completed an inspection of Octapharma Plasma, Inc. - Norfolk on Mar 14, 2017 in Norfolk, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Norfolk, VA (United States)